Tricuspid Valve Disease
23
12
14
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.3%
1 terminated out of 23 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (23)
Hummingbird ICE Study
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
TRISCEND II Pivotal Trial
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
EFS of the DUO System for Tricuspid Regurgitation
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease
Philips Intracardiac Echocardiography (ICE) Clinical Registry
Quality of Life After Cardiac Surgery
Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)
The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy
TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.
European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study
PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry
Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation